What should I Know Regarding Pregnancy, Nursing and Administering Zirabev 25 Mg/Ml Intravenous Solution Vascular Endothelial Growth Factor(VEGF) Monoclonal Antibody to Children or the Elderly?
If you are PREGNANT
- Known or Theoretical Risk:
If you are NURSING
- Absolute Contraindication: INSUFF DATA; MFR RECS AVOID DURING BREASTFEEDING AND 6 MO AFTER LAST DOSE
If you are an adult over 60
- Management or Monitoring Precaution: General-Increased risk for severe side effects, including sepsis, deep thrombophlebitis, arterial thromboembolism, hypertension, hypotension, edema, MI, GI hemorrhage.
Giving Zirabev 25 Mg/Ml Intravenous Solution Vascular Endothelial Growth Factor(VEGF) Monoclonal Antibody to a child under 12
- Severe Precaution: Non-mandibular osteonecrosis reported. No antitumor activity observed in relapsed glioblastoma study. No safety and efficacy established.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.